Application of pedf-derived short peptides in tendon healing
A technology for short peptide and tendon injury, which can be used in medical preparations containing active ingredients, drug combinations, peptide/protein components, etc., and can solve problems such as time-consuming amplification process, cost, technology and safety problems and obstacles.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0013] Embodiments of the present invention relate to methods of treating tendon injuries using PEDF-derived short peptides (PDSP). Human pigment epithelium-derived factor (PEDF) is a secreted protein containing 418 amino acids with a molecular weight of approximately 50 kDa. PEDF is a multifunctional protein with various biological functions (see, eg, US Patent Application Publication No. 2010 / 0047212). Different peptide regions of PEDF were found to be responsible for different functions. For example, a 34-mer fragment (residues 44-77 of PEDF) has been identified as having anti-angiogenic activity, while a 44-mer fragment (residues 78-121 of PEDF) has been identified as having neurotrophic properties.
[0014] The inventors of the present invention found that certain short peptides of PEDF can be used in the treatment of tendon injuries. It was further found that the therapeutic effect may arise from the ability of these PDSPs to induce the expansion of CD146+ TSPCs. CD14...
PUM
| Property | Measurement | Unit |
|---|---|---|
| molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


